MDWDNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
MediWound Ltd.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 5, 2026
$12.70+0.85 (+7.17%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$6.10 (−32.43%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
MediWound Ltd. saw revenue fall 16.1% to $16.96M over fiscal 2025. Free cash flow was -$21.63M.
Revenue
$16.96M
-16.1% vs. a year earlier
Operating income
-$25.27M
FY2025
Free cash flow
-$21.63M
FY2025
EPS, diluted
-$2.10
FY2025
Key statistics
Valuation at the latest close; fundamentals over fiscal 2025, balances at Dec 31, 2025
Valuation
- Market cap
- –
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $16.96M
- EPS, diluted
- -$2.10
- Free cash flow
- -$21.63M
Twelve years at a glance
Fiscal years 2014 to 2025, USD
Revenue
$16.96M-16.1% YoY
Gross profit
$3.25M+23.5% YoY
Operating income
-$25.27M
EPS, diluted
-$2.10
Free cash flow
-$21.63M
Reported period